Epilepsy and Cannabinoids
Authors/Editors
Alexis Arzimanoglou
Ulrich Brandl
Helen Cross
Antonio Gil-Nagel
Lieven Lagae
Cecilie Johannessen Landmark
Nicola Specchio
Elizabeth Thiele
Publisher
John Libbey Eurotext
Additional Details
Length: 80 pages
Cost: 28.00 €
Type: E-Book
Table of Contents: Download
Sample Pages: Download
There has been growing interest in the use of cannabis-based products for the treatment of a wide range of diseases, including epilepsy.
A number of studies were published during the last 5 years demonstrating efficacy of purified CBD for the control of a large spectrum of seizure-types, particularly those observed in severe childhood epilepsies, such as Lennox- Gastaut and Dravet syndromes.
This book, co-authored by leaders in the field of epileptology, critically reviews recent data from clinical trials. Authors discuss issues related to pharmacology, drug interactions, efficacy, potential adverse events and long-term effects on development and behaviour. Child and adult neurologists and all clinicians contributing to epilepsy care will find useful information on the best practices, when using purified CBD for the treatment of drug-resistant epilepsies.
ISBN : 978-2-7420-1633-4
Views: Last Updated: January 18, 2021
Subscribe to the ILAE Newsletter
To subscribe, please click on the button below.
Please send me information about ILAE activities and other
information of interest to the epilepsy community